Zogenix Sues Apotex to Block Copies of Fintepla Seizure Drug – Bloomberg Law
Zogenix seeks court order blocking copies until patents expire, says complaint filed Monday in federal court in Wilmington, Delaware; Fintepla is oral …
In: PATENT NEWS
Zogenix seeks court order blocking copies until patents expire, says complaint filed Monday in federal court in Wilmington, Delaware; Fintepla is oral …
In: PATENT NEWS
Two judges on a Federal Circuit panel appeared skeptical at oral argument of the California Institute of Technology’s billion-dollar patent infringement …
In: PATENT NEWS
Hello all, As a fresh college graduate with a Mechanical Engineering degree, I have finally figured out what career I would like to pursue; this …
In: PATENT NEWS
With a strong focus on patents—including defense of inventor rights at all ecosystem … as one of the top intellectual property law firms by IP Watchdog.
In: PATENT NEWS
The meeting provided several valuable networking opportunities and covered important topics and events across the industry. To join the WSG Patent Law Group: …
In: PATENT NEWS
patent law, any person who “invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement …
In: PATENT NEWS
Eagle is seeking court orders blocking manufacture and sale of the Slayback and Apotex products until patent expires in January 2031 and cash compensation …
In: PATENT NEWS
Readers will find a brief discussion of Brancusi v. United States in Martha Buskirk’s new study of contemporary art and intellectual property law, Is It Ours?:
In: PATENT NEWS
Ranked Band 1 Nationwide for IP Litigation and named Intellectual Property Law Firm of the Year by Chambers USA, which recognizes legal teams for “pre-eminence …
In: PATENT NEWS
The ruling in HTC Corp v Telefonaktiebolaget LM Ericsson saw the Fifth Circuit determine that breach-of-contract law – not patent law – should govern …
Designed by Industrial Action
Copyright © 2025 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION